Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant ...
Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback